Retina-IA: a feasible and cost-effective solution for early detection of diabetic retinopathy

GUADALAJARA, Mexico - Nov. 22, 2024 - PRLog -- A groundbreaking pilot project, Retina-IA, has successfully harnessed the power of artificial intelligence (AI) to revolutionize the early detection of diabetic retinopathy, a leading cause of blindness. Implemented in first-level clinics in Guadalajara, Mexico, Retina-IA has demonstrated the potential of AI to transform healthcare.

Traditionally, detecting this condition requires specialized equipment and ophthalmologist expertise, making it inaccessible to many in emerging countries. Retina-IA addresses this challenge by integrating AI-powered telemedicine into primary care settings.

"Diabetic retinopathy is a significant concern across Mexico due to its chronic and progressive nature. The disease has no symptoms in its early stages, and when diagnosed, is often so advanced that vision loss is inevitable. Although it cannot be cured, its progression can be controlled if detected in time," says Enrique Cortes-Rello, leader of the Artificial Intelligence Initiative at the School of Engineering and Sciences of Tecnologico de Monterrey, the number one university in engineering and technology in Mexico, according to QS World Ranking 2025.

The cost-benefit analysis of the Retina-IA project, conducted in collaboration with the Inter-American Development Bank, demonstrated that this approach is not only feasible, but also highly cost-effective. According to the economic evaluation, for each dollar invested in the project (technology, infrastructure, and people), between 3 and 10 dollars are generated in benefits for society (patients, their families, and the health system).

The project presents a solid proposal for scalability and replicability in other regions of Mexico and other emerging countries.

The main economic benefits include improvements in labor productivity and significant savings for the public health system. By preventing blindness and other severe complications of diabetic retinopathy, patients can maintain their work capacity and actively contribute to the economy, while the health system reduces costs associated with advanced treatments and long-term care.

Retina-IA also has a positive impact on patients' quality of life. Early detection and appropriate treatment not only prevent blindness but also improve the overall well-being of patients and their families. This preventive approach contributes to a healthier and more productive society, with fewer people suffering from visual disabilities that could have been prevented with an early diagnosis.